Abbott bought Cardiovascular Systems Cardiovascular Systems from 4/28/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Abbott has completed acquisition of Cardiovascular Systems for $890 million.

Cardiovascular Systems

Review

Source:

{source} pictogram

Vladimir Petenev

News editor

Write your comment first

News feed

SFI has repaid all of its debt

12/23/24 SFIN

Softline expects double-digit financial growth rates

12/23/24 SOFL

Abrau-Durso shareholders approved the additional share issue

12/20/24 ABRD

Betuvax has raised ₽100 million in venture capital investment

12/20/24 ABIO

Board of Directors of En+ Group extended the authority of CEO Vladimir Kolmogorov

12/20/24 ENPG

MTS expects revenue growth of approximately 14% in 2025

12/20/24 MTSS

Moscow Exchange's Supervisory Board extended Viktor Zhidkov's authority until 2027

12/20/24 MOEX

Tatneft shareholders have not yet approved dividends

12/20/24 TATN

MTS is headed by Inessa Galaktionova

12/20/24 MTSS

MTS will separate non-telecommunications business into separate legal entities

12/20/24 MTSS